Editorials

Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Division of experimental Oncology, IRCCS Istituto Scientifico San Raffaele e Università Vita-Salute San Raffaele, Milan, Italy
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands
Department of Internal Medicine III, Ulm University, Germany
Central European Institute of Technology, Masaryk University and University Hospital Brno, Czech Republic
Department of Haematology, Royal Bournemouth Hospital, UK
Haematology Department and Cancer Sciences Unit, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, University of Southampton, UK
Hematology Department and University Pierre et Marie Curie, Hopital Pitie-Salpetriere, Paris, France
Division of experimental Oncology, IRCCS Istituto Scientifico San Raffaele e Università Vita-Salute San Raffaele, Milan, Italy
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Vol. 102 No. 6 (2017): June, 2017 https://doi.org/10.3324/haematol.2017.165605